Keiji Tsuji

7PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 31, 2026
Multidisciplinary Treatment With Hepatic Arterial Infusion Chemotherapy, Radiotherapy, and Immunotherapy for Advanced Hepatocellular Carcinoma With Major Vascular Invasion: Prospective Registry Protocol.

Yoshiko Doi, Hiroshi Aikata, Yumi Kosaka

|Feb 07, 2026
Efficacy and Safety of Second-Line Lenvatinib After First-Line Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma.

Ryoichi Miura, Tomokazu Kawaoka, Saki Sueda

|Jan 12, 2026
Effect of Direct-Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japan.

Hironori Ochi, Masayuki Kurosaki, Takaaki Tanaka

|Dec 22, 2025
Biopsy-Proven Reversal of F4 Cirrhosis in Classic Hepatic Glycogen Storage Disease Type IV: A 42-Year Follow-Up Without Transplantation.

Masaaki Mino, Nami Mori, Yumi Shimomura

|Sep 29, 2025
Identification and Characterization of Three Novel Biomarkers for Mixed/Cholestatic Drug-Induced Liver Injury.

Kosuke Saito, Tatehiro Kagawa, Keiji Tsuji

|Sep 11, 2025
Effect of Pemafibrate on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Multicenter Study.

Yasuyuki Komiyama, Nobuharu Tamaki, Keiji Tsuji

Pageof 2

Frequent Collaborators

3 joint publications

Shiro Oka

3 joint publications

Masataka Tsuge

2 joint publications

Hironori Ochi

2 joint publications

Chikara Ogawa